Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 20.46% vs 16.66% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -1,866.67% vs 100.28% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 29.41% vs 120.20% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is -5.77% vs 4.00% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Jiangxi Fushine Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 20.46% vs 16.66% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -18.18% vs -25.57% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -1,866.67% vs 100.28% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 59.70% vs 23.32% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 29.41% vs 120.20% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 4,300.00% vs -69.70% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is -5.77% vs 4.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -1.01% vs -5.71% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






